Concepts (151)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Zebrafish | 20 | 2024 | 402 | 6.550 |
Why?
|
| Zebrafish Proteins | 12 | 2024 | 121 | 4.580 |
Why?
|
| Embryo, Nonmammalian | 11 | 2024 | 137 | 2.420 |
Why?
|
| Receptors, G-Protein-Coupled | 5 | 2024 | 291 | 2.270 |
Why?
|
| Endocrine Disruptors | 5 | 2022 | 53 | 1.910 |
Why?
|
| Receptors, Aryl Hydrocarbon | 3 | 2026 | 70 | 1.670 |
Why?
|
| Receptors, Estrogen | 8 | 2019 | 714 | 1.580 |
Why?
|
| Aryl Hydrocarbon Receptor Nuclear Translocator | 2 | 2023 | 2 | 1.570 |
Why?
|
| Estradiol | 8 | 2020 | 476 | 1.520 |
Why?
|
| Estrogens | 8 | 2022 | 424 | 1.300 |
Why?
|
| Response Elements | 2 | 2026 | 99 | 1.060 |
Why?
|
| Green Fluorescent Proteins | 5 | 2016 | 376 | 1.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2026 | 147 | 0.920 |
Why?
|
| Edema, Cardiac | 1 | 2024 | 3 | 0.910 |
Why?
|
| Receptors, Androgen | 3 | 2024 | 402 | 0.860 |
Why?
|
| Models, Animal | 3 | 2024 | 452 | 0.820 |
Why?
|
| Liver | 4 | 2026 | 1764 | 0.800 |
Why?
|
| Adaptive Immunity | 1 | 2024 | 99 | 0.800 |
Why?
|
| Larva | 4 | 2017 | 253 | 0.790 |
Why?
|
| Animals, Genetically Modified | 8 | 2022 | 326 | 0.750 |
Why?
|
| Adjuvants, Immunologic | 1 | 2024 | 380 | 0.750 |
Why?
|
| Animals | 24 | 2026 | 33120 | 0.710 |
Why?
|
| Immunity, Innate | 1 | 2024 | 394 | 0.710 |
Why?
|
| Genes, Reporter | 3 | 2022 | 344 | 0.700 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2021 | 89 | 0.690 |
Why?
|
| Water Pollutants, Chemical | 2 | 2019 | 36 | 0.670 |
Why?
|
| Receptors, Steroid | 1 | 2021 | 162 | 0.670 |
Why?
|
| DNA | 1 | 2026 | 1422 | 0.660 |
Why?
|
| Endothelial Cells | 1 | 2023 | 505 | 0.620 |
Why?
|
| Animal Fins | 1 | 2019 | 2 | 0.620 |
Why?
|
| Polychlorinated Dibenzodioxins | 1 | 2019 | 6 | 0.620 |
Why?
|
| Cardiotoxicity | 1 | 2019 | 40 | 0.610 |
Why?
|
| Vaccines | 1 | 2024 | 380 | 0.600 |
Why?
|
| Testosterone | 1 | 2024 | 600 | 0.600 |
Why?
|
| Sex Determination Analysis | 1 | 2018 | 15 | 0.590 |
Why?
|
| Gene Expression Regulation, Developmental | 5 | 2024 | 973 | 0.560 |
Why?
|
| Sex Differentiation | 1 | 2018 | 16 | 0.560 |
Why?
|
| Oogenesis | 1 | 2018 | 48 | 0.550 |
Why?
|
| Skull | 1 | 2019 | 147 | 0.550 |
Why?
|
| Genomics | 1 | 2026 | 1571 | 0.550 |
Why?
|
| Craniofacial Abnormalities | 1 | 2019 | 252 | 0.530 |
Why?
|
| Receptor Cross-Talk | 1 | 2017 | 36 | 0.530 |
Why?
|
| Microscopy, Fluorescence | 3 | 2016 | 307 | 0.520 |
Why?
|
| Spermatogenesis | 1 | 2018 | 169 | 0.510 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2017 | 189 | 0.500 |
Why?
|
| Ovary | 1 | 2018 | 358 | 0.480 |
Why?
|
| Testis | 1 | 2018 | 406 | 0.470 |
Why?
|
| Heart Rate | 1 | 2017 | 567 | 0.440 |
Why?
|
| Molecular Imaging | 1 | 2011 | 60 | 0.340 |
Why?
|
| Gene Expression Regulation | 3 | 2026 | 2313 | 0.310 |
Why?
|
| Transcriptional Activation | 1 | 2011 | 413 | 0.310 |
Why?
|
| Signal Transduction | 7 | 2024 | 4468 | 0.310 |
Why?
|
| Estrogen Antagonists | 3 | 2016 | 94 | 0.310 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2017 | 1593 | 0.290 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 235 | 0.270 |
Why?
|
| Nucleotide Motifs | 1 | 2026 | 48 | 0.240 |
Why?
|
| Cell Nucleus | 2 | 2018 | 554 | 0.230 |
Why?
|
| Ligands | 2 | 2016 | 477 | 0.210 |
Why?
|
| Mutation | 3 | 2024 | 5926 | 0.190 |
Why?
|
| Androgens | 1 | 2024 | 270 | 0.190 |
Why?
|
| Dimerization | 1 | 2022 | 135 | 0.190 |
Why?
|
| Aging | 1 | 2008 | 1187 | 0.180 |
Why?
|
| Mammals | 1 | 2022 | 250 | 0.170 |
Why?
|
| Biliary Tract | 1 | 2020 | 11 | 0.170 |
Why?
|
| Ethinyl Estradiol | 2 | 2017 | 11 | 0.170 |
Why?
|
| Estrogen Receptor beta | 1 | 2020 | 81 | 0.160 |
Why?
|
| Heart | 1 | 2024 | 650 | 0.160 |
Why?
|
| Phenols | 2 | 2017 | 64 | 0.160 |
Why?
|
| Folate Receptor 1 | 1 | 2019 | 30 | 0.160 |
Why?
|
| Embryonic Development | 2 | 2019 | 212 | 0.150 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2019 | 39 | 0.150 |
Why?
|
| Benzhydryl Compounds | 2 | 2017 | 72 | 0.150 |
Why?
|
| Cell Membrane | 1 | 2021 | 449 | 0.150 |
Why?
|
| Male | 8 | 2026 | 62089 | 0.150 |
Why?
|
| Sex Ratio | 1 | 2018 | 11 | 0.150 |
Why?
|
| Time Factors | 3 | 2017 | 6016 | 0.140 |
Why?
|
| Halogenated Diphenyl Ethers | 1 | 2017 | 12 | 0.140 |
Why?
|
| Triiodothyronine | 1 | 2017 | 55 | 0.140 |
Why?
|
| Pituitary Gland | 1 | 2017 | 77 | 0.130 |
Why?
|
| Folic Acid | 1 | 2019 | 277 | 0.130 |
Why?
|
| Female | 9 | 2020 | 67915 | 0.130 |
Why?
|
| Cyclosporine | 1 | 2017 | 126 | 0.130 |
Why?
|
| Brain | 1 | 2008 | 3032 | 0.130 |
Why?
|
| Oocytes | 1 | 2018 | 278 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 1 | 2026 | 4496 | 0.130 |
Why?
|
| Fertility | 1 | 2018 | 249 | 0.120 |
Why?
|
| Workflow | 1 | 2016 | 133 | 0.110 |
Why?
|
| Hemangioblasts | 1 | 2014 | 2 | 0.110 |
Why?
|
| Automation | 1 | 2014 | 65 | 0.110 |
Why?
|
| Transcription Factors | 1 | 2023 | 2341 | 0.100 |
Why?
|
| Genotype | 1 | 2018 | 2600 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2014 | 330 | 0.090 |
Why?
|
| Phytoestrogens | 1 | 2011 | 13 | 0.090 |
Why?
|
| Consensus Sequence | 1 | 2011 | 51 | 0.090 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2011 | 14 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2011 | 50 | 0.090 |
Why?
|
| Age Factors | 1 | 2017 | 2772 | 0.090 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2014 | 500 | 0.080 |
Why?
|
| Organ Specificity | 1 | 2011 | 396 | 0.080 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2019 | 968 | 0.080 |
Why?
|
| Uterus | 1 | 2014 | 533 | 0.080 |
Why?
|
| Mice | 1 | 2026 | 17585 | 0.070 |
Why?
|
| Humans | 6 | 2024 | 126089 | 0.070 |
Why?
|
| Endocrine System | 1 | 2008 | 18 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 1350 | 0.070 |
Why?
|
| Hepatocytes | 2 | 2020 | 232 | 0.070 |
Why?
|
| Morpholinos | 2 | 2020 | 9 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 1 | 2011 | 1207 | 0.070 |
Why?
|
| Germ Cells | 1 | 2008 | 196 | 0.070 |
Why?
|
| Transcriptome | 1 | 2013 | 1061 | 0.060 |
Why?
|
| Cell Line | 2 | 2020 | 2565 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 1099 | 0.060 |
Why?
|
| Neurons | 1 | 2011 | 1919 | 0.040 |
Why?
|
| Toxicity Tests | 1 | 2019 | 34 | 0.040 |
Why?
|
| HIV Integrase Inhibitors | 1 | 2019 | 14 | 0.040 |
Why?
|
| Oxazines | 1 | 2019 | 27 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 372 | 0.040 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2019 | 51 | 0.040 |
Why?
|
| Liver Regeneration | 1 | 2019 | 38 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2019 | 25 | 0.040 |
Why?
|
| Pyridones | 1 | 2019 | 135 | 0.040 |
Why?
|
| Tumor Burden | 1 | 2019 | 229 | 0.040 |
Why?
|
| Piperazines | 1 | 2019 | 250 | 0.030 |
Why?
|
| Organ Size | 1 | 2019 | 435 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2019 | 415 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 2019 | 438 | 0.030 |
Why?
|
| Stem Cells | 1 | 2020 | 676 | 0.030 |
Why?
|
| Carcinogenesis | 1 | 2019 | 343 | 0.030 |
Why?
|
| Sex Factors | 1 | 2019 | 1294 | 0.030 |
Why?
|
| Receptors, Estradiol | 1 | 2014 | 2 | 0.030 |
Why?
|
| T-Cell Acute Lymphocytic Leukemia Protein 1 | 1 | 2014 | 9 | 0.030 |
Why?
|
| Ephrin-B2 | 1 | 2014 | 9 | 0.030 |
Why?
|
| Gene Expression | 1 | 2019 | 1485 | 0.030 |
Why?
|
| Heat-Shock Response | 1 | 2014 | 33 | 0.030 |
Why?
|
| Genistein | 1 | 2014 | 39 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2014 | 66 | 0.030 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2014 | 39 | 0.030 |
Why?
|
| Gene Ontology | 1 | 2013 | 53 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2020 | 1849 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2013 | 148 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2013 | 450 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2013 | 410 | 0.020 |
Why?
|
| Receptors, Notch | 1 | 2014 | 195 | 0.020 |
Why?
|
| Liver Cirrhosis | 1 | 2019 | 876 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2019 | 2389 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 1225 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2014 | 588 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 1002 | 0.020 |
Why?
|
| Estrogen Receptor alpha | 1 | 2013 | 419 | 0.020 |
Why?
|
| HIV Infections | 1 | 2019 | 1948 | 0.020 |
Why?
|
| Pregnancy | 1 | 2019 | 7404 | 0.020 |
Why?
|